Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal opioid-free anesthesia containing esketamine versus opioid-based anesthesia: a systematic review and meta-analysis.

BMC anesthesiology·2026
Same author

Efficacy, tolerability, and safety of 1.5L-lactulose as bowel preparation for patients with inflammatory bowel disease: a randomized, single-blinded trial.

Internal and emergency medicine·2026
Same author

Ellagic acid alleviates ulcerative colitis in a GPR35-dependent manner associated with SDH restoration.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

N-Glycosylation and Alzheimer's disease: A 2001-2025 global bibliometric landscape revealing emerging diagnostic trends.

Journal of Alzheimer's disease reports·2026
Same author

Association of the Albumin-Bilirubin score with 7-day incident delirium risk following bloodstream infection in critically ill adults: evidence from a propensity-weighted cohort.

BMC infectious diseases·2026
Same author

Renal Tubule-Specific Deletion of Nephrocystin 3 <i>(Nphp3)</i> Causes Infantile Nephronophthisis-like Phenotypes in Mice.

International journal of molecular sciences·2026
Same journal

A Hybrid Experimental and in silico Platform for ITPK1 Chemical Probe Discovery.

SLAS discovery : advancing life sciences R & D·2026
Same journal

Tumor-versus-nonmalignant quantitative drug sensitivity profiling identifies capivasertib as a selective therapeutic candidate for nasopharyngeal carcinoma.

SLAS discovery : advancing life sciences R & D·2026
Same journal

ADCs for colorectal carcinoma: decoding clinical evidence for molecular design innovation.

SLAS discovery : advancing life sciences R & D·2026
Same journal

CellVision: A deep learning based image analysis platform to accelerate immuno-plaque assay data processing for dengue vaccine development.

SLAS discovery : advancing life sciences R & D·2026
Same journal

Use t tests to analyze counts of cells in two states.

SLAS discovery : advancing life sciences R & D·2026
Same journal

In silico prioritization and cheminformatics identify structurally diverse small-molecule inhibitors of Lassa virus glycoprotein-mediated membrane fusion.

SLAS discovery : advancing life sciences R & D·2026
See all related articles

Related Experiment Video

Updated: Mar 2, 2026

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening
05:54

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

9.1K

Three-Dimensional Cell Cultures in Drug Discovery and Development.

Ye Fang1, Richard M Eglen2

  • 11 Biochemical Technologies, Corning Research and Development Corporation, Corning Incorporated, Corning, NY, USA.

SLAS Discovery : Advancing Life Sciences R & D
|May 19, 2017
PubMed
Summary
This summary is machine-generated.

Three-dimensional (3D) cell cultures, including spheroids and organoids, are revolutionizing drug discovery. These advanced models improve disease modeling and therapeutic development, enhancing efficacy and safety assessments.

Keywords:
3D bioprinting3D cell culturedisease modelsefficacymulticellular spheroidorganoidsorgans-on-chipssafetyscreeningtoxicity

More Related Videos

Semi-Automated Phenotypic Analysis of Functional 3D Spheroid Cell Cultures
06:48

Semi-Automated Phenotypic Analysis of Functional 3D Spheroid Cell Cultures

Published on: August 18, 2023

99.4K
Ordering Single Cells and Single Embryos in 3D Confinement: A New Device for High Content Screening
14:22

Ordering Single Cells and Single Embryos in 3D Confinement: A New Device for High Content Screening

Published on: September 18, 2016

9.0K

Related Experiment Videos

Last Updated: Mar 2, 2026

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening
05:54

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

9.1K
Semi-Automated Phenotypic Analysis of Functional 3D Spheroid Cell Cultures
06:48

Semi-Automated Phenotypic Analysis of Functional 3D Spheroid Cell Cultures

Published on: August 18, 2023

99.4K
Ordering Single Cells and Single Embryos in 3D Confinement: A New Device for High Content Screening
14:22

Ordering Single Cells and Single Embryos in 3D Confinement: A New Device for High Content Screening

Published on: September 18, 2016

9.0K

Area of Science:

  • Biotechnology
  • Cell Biology
  • Pharmacology

Background:

  • Three-dimensional (3D) cell cultures are increasingly utilized to better replicate in vivo physiological conditions compared to traditional 2D methods.
  • These advanced culture systems are transitioning from research tools to potential therapeutic agents for various diseases.

Purpose of the Study:

  • To review and assess leading 3D cell culture technologies and their applications in drug discovery.
  • To discuss the integration of these technologies in compound identification, screening, and development processes.

Main Methods:

  • Review of current literature on 3D cell culture technologies.
  • Analysis of applications including spheroids, organoids, scaffolds, hydrogels, organs-on-chips, and 3D bioprinting.
  • Discussion of implementation in disease modeling, efficacy, and safety profiling.

Main Results:

  • 3D cell culture technologies offer enhanced physiological relevance for drug discovery.
  • These methods facilitate improved disease modeling and prediction of therapeutic outcomes.
  • Diverse 3D platforms provide versatile tools for various stages of drug development.

Conclusions:

  • 3D cell culture technologies represent a significant advancement in pharmaceutical research and development.
  • Their application enhances the accuracy of preclinical drug testing and therapeutic potential assessment.
  • Continued innovation in 3D culture systems promises to accelerate the development of novel treatments.